Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Tipping Backlash Has Begun
It appears that people are cutting back on tipping with gratuity requests spreading far beyond bars and restaurants.
Load More